Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0321611001
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Cancelled Post Market | 02244011 | ROUGIER PHARMA DIVISION OF RATIOPHARM INC | BALMINIL CODEINE + DECONGESTANT + EXPECTORANT | Human | No | Narcotic (CDSA I) | 3 | CODEINE PHOSPHATE | 3.3 MG / 5 ML |
Cancelled Post Market | 02245709 | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | BENYLIN 2 COLD AND FLU WITH CODEINE | Human | No | Narcotic (CDSA I) | 3 | GUAIFENESIN | 100 MG / 5 ML |
Cancelled Post Market | 01944703 | PFIZER CANADA INC., CONSUMER HEALTHCARE DIVISION | BENYLIN CODEINE 3.3MG DE SYR | Human | No | Narcotic (CDSA I) | 3 | GUAIFENESIN | 100 MG / 5 ML |
Cancelled Post Market | 00889873 | TECHNILAB PHARMA INC. | CALMYLIN CODEINE D-E SYR | Human | No | Narcotic | 3 | CODEINE PHOSPHATE | 3.3 MG / 5 ML |
Marketed | 02172917 | TEVA CANADA LIMITED | CALMYLIN PSE WITH CODEINE | Human | Yes | Narcotic (CDSA I) | 3 | CODEINE PHOSPHATE | 3.3 MG / 5 ML |
Cancelled Post Market | 02024810 | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | COUGH SYR W.COD. PSEUDOEPHED.HCL GUAIFENESIN | Human | No | Narcotic (CDSA I) | 3 | CODEINE PHOSPHATE | 3.3 MG / 5 ML |
Marketed | 02099748 | TEVA CANADA LIMITED | COUGH SYRUP WITH CODEINE | Human | No | Narcotic (CDSA I) | 3 | CODEINE PHOSPHATE | 3.3 MG / 5 ML |
Dormant | 02258099 | JAMP PHARMA CORPORATION | COUGH SYRUP WITH CODEINE | Human | No | Narcotic (CDSA I) | 3 | CODEINE PHOSPHATE | 3.3 MG / 5 ML |
Approved | 02322196 | CELLCHEM PHARMACEUTICALS INC. | COUGH SYRUP WITH CODEINE | Human | No | Narcotic (CDSA I) | 3 | CODEINE PHOSPHATE | 3.3 MG / 5 ML |
Application information
Related information
Contact us
Version 4.0.3